abstract |
The application provides a composition comprising a canine influenza virus and a dog respiratory coronavirus. The composition may further comprise Bordetella bronchiseptica , pertactin, canine parainfluenza virus and canine adenovirus serotype 2. The composition is effective for treating or preventing dog respiratory diseases, including dog infectious respiratory complex diseases. |